| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/15/2004 | WO2003030913A3 Use of dendrimers in an ophthalmic composition |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003013433A3 Sequestered antagonist formulations |
| 04/15/2004 | WO2003002059A3 Tolterodine metabolites |
| 04/15/2004 | WO2002067854A3 Manufacture of thyroid hormone tablets having consistent active moiety amounts |
| 04/15/2004 | WO2002060389A3 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | WO2001082892A3 Liposomes containing active substances |
| 04/15/2004 | US20040073258 Body tissue and skin treatment method using pulsing heating pad and topical cream |
| 04/15/2004 | US20040073197 Selective peripheral nerve plexus implantable infusion device and method |
| 04/15/2004 | US20040073196 Vascular access port with needle detector |
| 04/15/2004 | US20040072986 Ring opening polymerization of lactide, glycolide in presence of dextran sulfate in an extruder; sustained release; drug delivery |
| 04/15/2004 | US20040072961 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 04/15/2004 | US20040072912 Wet granulation; drying in fluidized bed; compression |
| 04/15/2004 | US20040072911 Mixture of antiseptic, bactericide and lubricant |
| 04/15/2004 | US20040072910 AIDS prophylactic lubricating composition |
| 04/15/2004 | US20040072909 Veterinary compositions for the treatment of parasitic diseases |
| 04/15/2004 | US20040072906 Adjust blood-sugar concentration using plant extract |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072901 Corosolic acid formulation and its application for weight-loss management and blood sugar balance |
| 04/15/2004 | US20040072894 Anticholesterol agents; compressed into tablets |
| 04/15/2004 | US20040072891 Urogenital disorders |
| 04/15/2004 | US20040072841 Topical administration of oxazolidinones for transdermal delivery |
| 04/15/2004 | US20040072810 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| 04/15/2004 | US20040072809 Antiinflammatory agents; analgesics; dilation; reducing pressure; therapy for vision defects |
| 04/15/2004 | US20040072799 Drug delivery; mixture of cyclodextrin and amphiphilic copolymer |
| 04/15/2004 | US20040072797 In liquid siolvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/15/2004 | US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents |
| 04/15/2004 | US20040072793 Amide derivatives; scaffold for tissue regeneration; drug delivery biodegradable; tissue adhesive |
| 04/15/2004 | US20040072789 Veterinary composition for the topical treatment of traumatized or inflamed skin |
| 04/15/2004 | US20040072784 Micelles formed from amphiphilic polymers associate or dissociate reversibly upon ph changes; oral or parenteral delivery of hydrophobic or cationic pharmaceutical; copolymer of polyethylene oxide and polyacrylic acid-butyl acrylate |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072735 Administering suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylase (HDAC) to a patient for cancer cell growth arrest and/or apoptosis of neoplastic cells |
| 04/15/2004 | US20040072733 Anti-viral composition |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072724 A first eatable gel containing a medicine and having a resolvability in the digestive tract, and a second eatable gel containing a medicine and showing a behavior in the digestive tract different from that of first eatable gel |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072258 Disruption of a Ras-protein complex by a Ras antagonist, e.g.,farensylthiosalicylic acid, analyzed; identifying drug candidates inhibiting aberrant Ras activity; binding andinactivating mRNA of anchor protein by a oligonucleotides |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040071906 Surface modification process |
| 04/15/2004 | US20040071798 Administering to a mammal in acosmetic/dermatological formulation which comprises intimate admixture of at least one carotenoid and at least one extract of at least one plant of genus Rosmarinus for therapy of skin aging |
| 04/15/2004 | US20040071785 Solvent-free; coating and stirring in soluble supercritical fluid |
| 04/15/2004 | US20040071784 Composite material and process for increasing bioavailability and activity of a beneficial agent |
| 04/15/2004 | US20040071783 Contacting solution or suspension of target in vessel with supercritical fluid; precipitation |
| 04/15/2004 | US20040071782 Ionophore antibiotic formulations |
| 04/15/2004 | US20040071780 Crosslinking alginate using epichlorohydrin; forming microspheres; coating with chitosan and polycaprolactone; drug delivery; vaccines |
| 04/15/2004 | US20040071778 Gel administered as drops or ointment with free-flowing vehicle and benzyllauryldimethylammonium chloride preservative |
| 04/15/2004 | US20040071777 In hydrophilic cellulose ether, polyvinyl pyrrolidone, or polyethylene glycol; amorphous |
| 04/15/2004 | US20040071776 Diameter of pores of support netweork greater than those of filling; vascular occlusions (embolizations), cellular reconstruction, treatment of gastroesophageal reflux, incontinence, and wrinkle resistance |
| 04/15/2004 | US20040071775 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 04/15/2004 | US20040071774 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 04/15/2004 | US20040071773 Quick disintegrating tablet in buccal cavity and manufacturing method thereof |
| 04/15/2004 | US20040071772 Spray-dried powder comprising sugar alcohol; compression molded tablet; drug delivery to infants |
| 04/15/2004 | US20040071771 Fenofibrate-containing composition |
| 04/15/2004 | US20040071770 Free radical scavenging liposome containing mixture of beta-carotene, vitamin E, vitamin C, glutathione, niacin, and/or trace metal; quenching |
| 04/15/2004 | US20040071769 Buffer, surfactant, chelate compound, nonionic preservative microbiocide; sensitivity; wound healing agents; topical, drug delivery |
| 04/15/2004 | US20040071768 Compositions and methods for treating cancer |
| 04/15/2004 | US20040071767 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 04/15/2004 | US20040071766 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 04/15/2004 | US20040071765 Electrconductive layer containing basic and/or acidic water swelling methacrylate copolymer; transdermal drug delivery |
| 04/15/2004 | US20040071764 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 04/15/2004 | US20040071763 Composition for use in electroporation |
| 04/15/2004 | US20040071761 Non-invasive ocular drug delivery |
| 04/15/2004 | US20040071760 Therapeutic film forming composition and treatment system therefor |
| 04/15/2004 | US20040071757 Inhalation antiviral patch |
| 04/15/2004 | US20040071755 Water soluble sheet composition |
| 04/15/2004 | US20040071754 Oral contact sanitizing wipes (ORCO Sanitizing wipes) |
| 04/15/2004 | US20040071744 Gene expression inhibition of collagenases; skin wrinkle resistance |
| 04/15/2004 | US20040071740 Mixture of hyaluronic acids of different molecular weights in diluent |
| 04/15/2004 | US20040071732 Film coating material |
| 04/15/2004 | US20040071727 Method of vaccinating vertebrates |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071716 An adjuvant is used in vaccine formulation, comprising a polymeric emulsifier Arlacel" or ATLOX"; stable, low viscosity |
| 04/15/2004 | US20040071715 A capsule comprising a formaldehyde-treated antigens dispersed within a biocompatible polymer and an amino acid stabilizer as antiagglomerants; sustained release |
| 04/15/2004 | US20040071685 Compositions and methods for increasing the bioavailability of plant polyphenols |
| 04/15/2004 | US20040071682 Super absorption coenzyme Q10 |
| 04/15/2004 | US20040071664 Delivery of an agent |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | US20040071645 Glucocorticoid formulation; penetration, bioavailability |
| 04/15/2004 | US20040071635 Very small diameter; free flowing; promoting dispersal of dry powder inhalant |
| 04/15/2004 | US20040070102 Novel process |
| 04/15/2004 | US20040070093 Dissolving a polymer in a solvent, dissolving or dispersing an an agent in the solvent, and introducing a nonsolvent to cause the spontaneous formation of a microencapsulated product; at least 10 times more nonsolvent than solvent |
| 04/15/2004 | US20040069632 Applying an electrical potential to a set of feeding tips which have immiscible running through them; electro-hydrodynamic forces are used to generate coaxial jets and to stretch them out to the desired sizes. |
| 04/15/2004 | US20040069300 For the production of capsules and coatings for solid formulations in drug, cosmetic, food and dietetic fields, and for coating seeds. |
| 04/15/2004 | DE20318006U1 Adhesive inhalation device for application to an area between the top lip and the nose comprises perforated protective layer and evaporation element on top of barrier, base and adhesive layers |
| 04/15/2004 | DE19906975B4 Arzneiform zur Behandlung von Alzheimer'scher Demenz Dosage form for the treatment of Alzheimer's dementia |
| 04/15/2004 | DE10390696T5 Haftblatt zum Fördern des Blutkreislaufs unter Verwendung von Pyroligninflüssigkeit, und Verfahren zum Herstellen derselben Tack sheet for conveying the blood circuit using Pyroligninflüssigkeit, and methods for manufacturing the same |
| 04/15/2004 | DE10296335T5 Pharmazeutische Formulierungen Pharmaceutical formulations |
| 04/15/2004 | DE10246377A1 Production of plaster useful for prolonged release of active agent, especially essential oil, comprising coating one side of absorbent carrier with adhesive then charging opposite side with active agent |
| 04/15/2004 | CA2836959A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 04/15/2004 | CA2516547A1 Drug delivery device having coated microprojections incorporating vasoconstrictors |
| 04/15/2004 | CA2501981A1 Nitroxide radioprotector formulations and methods of use |
| 04/15/2004 | CA2501294A1 Spheroids, preparation process and pharmaceutical compounds |
| 04/15/2004 | CA2500822A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/15/2004 | CA2500722A1 Inorganic shaped bodies and methods for their production and use |
| 04/15/2004 | CA2500663A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | CA2500259A1 Potent inhibitor of hcv serine protease |